CHINA TRIP GIVES ST. CHARLES MAN HOPE
By Josh Stockinger | Daily Herald Staff
Dave Ozzello's walking cane isn't getting much use these days. As for his skis, well, that's a different story.
The St. Charles man, who has battled multiple sclerosis for 31 years, reports a drastic reduction in symptoms since going to China in August for umbilical cord stem cells. His energy's up. His balance is better. And this week the 51-year-old was hitting the slopes in Colorado. "I have not used my cane since I came back," Ozzello said of the treatment, not yet available in the United States‚¦
Dave Ozzello of St. Charles went to China in August for umbilical cord stem cell treatment of multiple sclerosis, which he has battled for more than 30 years.
To read the complete article:
FAMILY THRILLED BY SON'S RESPONSE TO CELL THERAPY
Dec. 27, 2007 by Dominic Jones, Gwent Gazette
THE FUTURE is looking bright for Britain'S youngest Motor Neurone Disease sufferer, as his (ADULT---dm) stem cell treatment seems to be making positive progres.
Michael Emms, aged 20, travelled to Shenyang Hospital in Beijing earlier this month to undergo radical treatment for his potentially fatal condition which is slowly degenerating his muscles.
Step-mum Joanna Stanley has revealed that Michael is already showing massive signs of improvement‚¦
To read the complete article:
Diabetics rush for 'cure'
'More and more energetic' ¦ Lynley White, 62, who has cardiomyopathy, had stem-cell treatment in Bangkok in October to improve her condition.
December 23, 2007
Page 1 of 2 | Single page
AUSTRALIANS with type 2 diabetes are signing up for a costly, unproven stem cell "cure" at a South American clinic.
The clinic says 89per cent of its patients are insulin and medication-free 90 days after being injected with their own stem cells. The treatment costs $US16,000 ($18,500).
Some patients who have undergone the same stem-cell therapy for heart disease - which is illegal in all Western countries - say it has given them "a new lease on life".
But the world's leading stem-cell scientists warn that patients desperate for a miracle cure are putting themselves at grave risk by undergoing a treatment yet to be fully tested in humans.
ICORM director Mike Bartlett said more than 300 patients had been successfully treated for heart disease, diabetes, emphysema and Parkinson's disease at its hospitals in South America and Asia.
Mr Bartlett spent last week in Sydney meeting diabetes specialists and cardiologists to encourage them to refer their end-stage patients.
To date, 31 Australians with type2 diabetes and seven with heart disease had indicated a wish to travel to Argentina as soon as possible, and a further 208 had made inquiries, he said.
Dr Ross Walker, a Sydney Adventist Hospital cardiologist and author of the bestselling book The Cell Factor, said he would travel to the Clinic early next year to assess the claims for himself.
"I believe it is the next big thing in medicine but I want to see solid scientific evidence that it doesn't do any harm before recommending it for the wider population," he said.
Under the patented process, 250millilitres of a patient's blood is manipulated to yield millions of therapeutic stem cells. The cells are then injected into the diseased organ or tissue. Patients are usually sent home within two days.
Numerous patients have testified to the "miraculous" effects of the treatment, which uses adult stem cells, not the more ethically-questionable embryonic stem cells
. Keith Fanning said the $70,000 he spent flying his dying father, Mick, 75, to Bangkok for stem-cell therapy was "the best $70,000 I ever spent". Oxygen-dependent and barely able to walk before the procedure in July, Mr Fanning's ejection fraction (EF) - the measurement of the capacity at which the heart is pumping - increased so much that he can now breathe, talk and eat on his own.
His insulin dependency is also down and his violent shaking from Parkinson's has virtually disappeared.
"I'm the ultimate sceptic and it's the closest thing I've seen to a miracle," he said from his Queensland home.
In October, Lynley White, from Melbourne, spent $45,000 to have 30 stem-cell injections in her heart after traditional drug therapy failed to improve her cardiomyopathy.
"My doctors laughed at me and said I had rocks in my head but so far so good. I'm feeling more and more energetic," she said.
At 62, she was unlikely to receive the heart transplant she needed to keep going. Of the 120 people who have tried the treatment at Bangkok Heart Hospital, four have died. But Mrs White said her only fear was she would not survive the anaesthetic.
"My ejection fraction was getting lower and lower - it got down to 12 when it should be 55 plus - and I thought 'I've got to help myself'," she said.
Immediately after treatment her EF rating was up by 64 per cent.
Dr Teija Peura, director of human embryonic stem cell laboratories at the Australian Stem Cell Centre, said: "It's understandable that patients who are desperate can't wait for treatment to go through the approval process but it's dangerous because these countries are giving treatment which they don't know how or why [it] works."
The International Society for Stem Cell Research said the only stem cell-based therapy with clearly proven efficacy was bone marrow transplantation for blood disorders and leukaemia.
New stem cell therapy in use against a range of illnesses
By DORSEY GRIFFITH
Article Last Updated: 12/19/2007 08:57:10 AM PST
SACRAMENTO They are not from human embryos, but the stem cells being packed into the spine of Perry Anderson may help him heal from a surgery that failed to heal the first time, leaving him hobbled and unable to work for nearly three years.
The same cells, derived from bone marrow, may also one day help heart attack patients recover, ease the misery of inflammatory bowel disease, and allow diabetics to continue producing insulin.While the ethical debate rages over the use of stem cells taken from discarded human embryos, bone marrow stem cells, harvested both from cadavers and from live donors, are being developed for use against a range of illnesses...
STEM CELLS RESHAPE BREASTS AFTER CANCER
WebMD Medical News - Breast Cancer Health Center
Four-Fifths of Women Satisfied With Cosmetic Results Following Breast Cancer Surgery
Dec. 17, 2007 (San Antonio) -- In a medical first, researchers have used stem cells to help reshape the breasts of women who have undergone a lumpectomy to remove a breast tumor‚¦
To read the complete article: